Canadians facing severe allergic reactions have a new way to access emergency medication. Neffy, an epinephrine nasal spray, is now available without a prescription at pharmacies across Canada following a new regulatory classification. This change expands access to regions where patients once had to present a doctor's note to obtain the medication.
How does the new epinephrine nasal spray work?
Neffy provides a needle-free alternative for treating anaphylaxis caused by food, medicine, insect stings, or exercise. While traditional treatments like EpiPens require an injection into the thigh, this spray is administered through the nose. Clinical studies conducted in 2024 involving healthy adults showed the spray was roughly as effective as injections at boosting heart rate and blood pressure during a reaction.
Key details regarding the current availability include:
- The 2 mg dose is authorized for adults and children weighing at least 30 kg (66 pounds).
- The product is classified as a Schedule II item, meaning it must be kept behind the pharmacy counter.
- A pharmacist must provide counseling to the consumer before the medication is dispensed.
Who can use this allergy treatment?
The current Canadian authorization applies to individuals weighing 30 kg or more. For younger patients weighing between 15 and 30 kg, the 1 mg dose of Neffy is not yet approved in Canada; currently, the EpiPen Jr. remains the primary option for this weight group.
While the spray offers a convenient alternative for those who avoid needles, users should be aware of potential side effects. According to the FDA, these may include nasal discomfort, sneezing, headaches, dizziness, or nausea.
FAQ
Do I need to see a doctor to get Neffy?
No, because it is now a Schedule II product, you can obtain it at a pharmacy without a prescription, though you must consult with the pharmacist first.
Is Neffy suitable for small children?
Only children weighing 30 kg (66 pounds) or more can use the currently approved 2 mg dose.
